348.40
-22.60
(-6.09%)
At close: 5:49:08 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 18 | 15 | 24 | 23 |
Avg. Estimate | 13.67B | 13.72B | 55.14B | 55.94B |
Low Estimate | 13.59B | 13.63B | 54.67B | 54.18B |
High Estimate | 13.74B | 13.81B | 55.69B | 57.09B |
Year Ago Sales | 13.68B | 13.69B | 55.09B | 55.14B |
Sales Growth (year/est) | -0.08% | 0.26% | 0.11% | 1.44% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0HW4.L | -- | -- | -- | -- |
S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
Maintains | Barclays: Underweight to Underweight | 2/3/2025 |
Maintains | RBC Capital: Sector Perform to Sector Perform | 2/3/2025 |
Reiterates | Benchmark: Buy to Buy | 1/31/2025 |
Maintains | RBC Capital: Sector Perform to Sector Perform | 1/15/2025 |
Upgrade | Keybanc: Sector Weight to Overweight | 12/12/2024 |
Upgrade | Exane BNP Paribas: Underperform to Neutral | 11/26/2024 |